Atlas Capital Advisors’s GoodRx Holdings GDRX Stock Holding History

Atlas Capital Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	-$592	–	944
2022 Q2	$592	Hold	100	–	–	﹤0.01%	945
2022 Q1	$1.93K	Hold	100	–	–	﹤0.01%	845
2021 Q4	$3.27K	Hold	100	–	–	﹤0.01%	825
2021 Q3	$4.1K	Hold	100	–	–	﹤0.01%	821
2021 Q2	$3.6K	Hold	100	–	–	﹤0.01%	847
2021 Q1	$3.9K	Buy	+100	New	+$4.5K	﹤0.01%	765

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Atlas Capital Advisors's GDRX Position: Q3 2022 in Review

Atlas Capital Advisors sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 100 shares — an estimated $592 sold.

Atlas Capital Advisors first reported a position in GDRX in Q1 2021 and held it in 6 quarters. The position peaked at $4.1K in Q3 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

Atlas Capital Advisors reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
Atlas Capital Advisors sold 100 GoodRx Holdings shares in Q3 2022, an estimated $592.
Atlas Capital Advisors first reported a position in GoodRx Holdings in Q1 2021 and held it in 6 quarters.
Atlas Capital Advisors's GoodRx Holdings position peaked at $4.1K in Q3 2021.
180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on Atlas Capital Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.